BeOne Medicines Ltd. (ONC)
376.88
+4.90
(+1.32%)
USD |
NASDAQ |
Aug 25, 16:00
376.88
0.00 (0.00%)
After-Hours: 17:32
BeOne Medicines Gross Profit Margin (Quarterly) : 87.80% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 87.80% |
| March 31, 2026 | 86.63% |
| December 31, 2025 | 88.43% |
| September 30, 2025 | 83.86% |
| June 30, 2025 | 85.47% |
| March 31, 2025 | 82.63% |
| December 31, 2024 | 83.02% |
| September 30, 2024 | 77.94% |
| June 30, 2024 | 82.58% |
| March 31, 2024 | 80.17% |
| December 31, 2023 | 79.74% |
| September 30, 2023 | 85.05% |
| June 30, 2023 | 80.26% |
| March 31, 2023 | 77.45% |
| December 31, 2022 | 76.12% |
| September 30, 2022 | 80.21% |
| June 30, 2022 | 74.87% |
| March 31, 2022 | 73.58% |
| December 31, 2021 | 71.48% |
| September 30, 2021 | 76.94% |
| June 30, 2021 | 68.22% |
| March 31, 2021 | 93.02% |
| Date | Value |
|---|---|
| December 31, 2020 | 71.12% |
| September 30, 2020 | 67.65% |
| June 30, 2020 | 66.22% |
| March 31, 2020 | 57.93% |
| December 31, 2019 | 55.23% |
| September 30, 2019 | 51.88% |
| June 30, 2019 | 91.15% |
| March 31, 2019 | 76.00% |
| December 31, 2018 | 79.15% |
| September 30, 2018 | 79.52% |
| June 30, 2018 | 83.82% |
| March 31, 2018 | 79.34% |
| December 31, 2017 | 72.95% |
| September 30, 2017 | 98.53% |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
| December 31, 2015 | 0.00% |
| September 30, 2015 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| CRISPR Therapeutics AG | -337.8% |
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| AC Immune SA | 0.00% |
| Idorsia Ltd. | 72.13% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 14.81% |
| Return on Assets | 8.24% |
| Return on Invested Capital | 10.52% |
| Profit Margin (Quarterly) | 13.90% |
| Operating Margin (Quarterly) | 19.06% |
| Return on Net Operating Assets | 18.95% |